Abstract
Background: From 2000-2014, Utah experienced a 400% increase in opioidrelated deaths and currently ranks 4th in the nation for such deaths. To address this problem, a policy was recently proposed by the Utah State Legislature that would require insurance prior authorization (PA) for certain high dose, long-acting opioid prescriptions. The purpose of this study is to analyze potential health impacts of the policy and to determine whether it would be an effective step in combatting Utah’s opioid problem. Methods: A rapid Health Impact Assessment (HIA) was performed to assess the potential health impacts of the proposed policy. Hypotheses were generated and a causal pathway was developed. Quantitative and qualitative data were gathered to assess each hypothesis and determine the direction, magnitude, likelihood, and distribution of each potential health impact. Results: Several positive and negative health impacts of the policy were examined. Negative health impacts that are likely include increased time and cost for prescribers, and increased patient stress and anxiety due to difficulties in filling prescriptions. Positive health impacts include a modest decrease in the amount of opioids prescribed and a modest decrease in opioid consumption, leading to a decrease in the number of persons addicted to prescription opioids. Conclusion: Given the potential for the proposed PA policy to decrease the number of opioid addicts, it is recommended that the Utah State Legislature move forward with the proposed policy. However, in order to mitigate potential negative health effects, it is recommended that pain specialists be exempt from opioid-related PA.
Highlights
Introduction and BackgroundUtah, like most of the United States, is experiencing an opioid abuse and overdose epidemic
Changes in costs to prescribers After interviewing several prescribers, it was concluded that requiring prior authorization (PA) for prescription opioids would greatly impact the practice of prescribers
Pain specialists write many prescriptions for highdose opioids that would require PA under this policy; as such, the implementation of this policy may be a great burden to pain specialists, due to increased costs and paperwork [8]
Summary
Like most of the United States, is experiencing an opioid abuse and overdose epidemic. Utah experienced a 400% increase in opioid misuse and abuse deaths from 2000-2014. From 20122014, Utah was ranked 4th in the nation for drug poisoning deaths, most of which were attributed to opioid overdose [1]. From 2000-2014, Utah experienced a 400% increase in opioidrelated deaths and currently ranks 4th in the nation for such deaths. To address this problem, a policy was recently proposed by the Utah State Legislature that would require insurance prior authorization (PA) for certain high dose, long-acting opioid prescriptions. The purpose of this study is to analyze potential health impacts of the policy and to determine whether it would be an effective step in combatting Utah’s opioid problem
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
